Benjamin A. Lipsky
Lipsky, Benjamin A.
VIAF ID: 315215840 (Personal)
Permalink: http://viaf.org/viaf/315215840
Preferred Forms
- 100 0 _ ‡a Benjamin A. Lipsky
-
- 100 1 _ ‡a Lipsky, Benjamin A.
-
-
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Drugs for bugs, 2002: | |
Fever in medical service patients | |
Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections | |
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update) | |
Hemophilus influenzae in Urine | |
How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers? | |
Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization withStaphylococcus aureus | |
The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds | |
In diabetic foot infections antibiotics are to treat infection, not to heal wounds | |
In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. | |
Infection of the Foot in Persons with Diabetes: Epidemiology, Pathophysiology, Microbiology, Clinical Presentation and Approach to Therapy | |
Inpatient management of diabetic foot disorders: a clinical guide | |
Is the clean-catch midstream void procedure necessary for obtaining urine culture specimens from men? | |
Laboratory diagnosis of urinary tract infections in men | |
Letter to the editors | |
Limb salvage in patients with diabetes is not a temporary solution but a life-changing procedure. | |
The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey. | |
Microbiologie et traitement antibiotique du pied diabétique infecté | |
The microbiology of bacteriuria in men: a 5-year study at a Veterans' Affairs hospital | |
Microbiology of diabetic foot infections: from Louis Pasteur to 'crime scene investigation'. | |
Nothing to Cough At | |
Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections | |
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT | |
The pneumococcal vaccine after 15 years of use. | |
Pneumococcal vaccine in the United States. A critical analysis | |
Preventing catheter-related bacteriuria: should we? Can we? How? | |
Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents. | |
Probe-to-Bone Test for Diagnosing Diabetic Foot Osteomyelitis: Reliable or relic? | |
A prospective study of Staphylococcus aureus nasal colonization and intravenous therapy-related phlebitis | |
A report from the international consensus on diagnosing and treating the infected diabetic foot | |
Response to Comment on: Lipsky and Berendt. Hyperbaric Oxygen Therapy for Diabetic Foot Wounds: Has Hope Hurdled Hype? Diabetes Care 2010;33:1143-1145 | |
Response to Comment on: Lipsky et al. Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection. Diabetes Care 2011;34:1695-1700 | |
Risk Factors for Acquiring Pneumococcal Infections | |
Risk factors for developing osteomyelitis in patients with diabetic foot wounds | |
Risk factors for nosocomial urinary tract–related bacteremia: A case-control study | |
The role of age in susceptibility to pneumococcal infections. | |
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials | |
Septic Tenosynovitis of the Hand: Factors Predicting Need for Subsequent Débridement | |
Set Phages to Stun: Reducing the Virulence of Staphylococcus aureus in Diabetic Foot Ulcers | |
Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. | |
Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes | |
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections. | |
Stopping Antibiotic Therapy for a Diabetic Foot Infection: Some Answers, but More Questions. | |
Surgical site infections: Causative pathogens and associated outcomes | |
Systemic antibiotic therapy for chronic osteomyelitis in adults | |
Topical antimicrobial therapy for treating chronic wounds | |
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: Sparfloxacin versus clarithromycin | |
Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate | |
Treating osteomyelitis: antibiotics and surgery | |
Treatment for diabetic foot ulcers | |
Treatment of bacterial prostatitis | |
Unsolved mysteries of UTIs in men. Commentary on A. J. Schaeffer's paper. | |
Use of cultures in cellulitis: when, how, and why? | |
Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review | |
Validation of the Infectious Diseases Society of America's Diabetic Foot Infection Classification System | |
Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine | |
What is the shelf life of physician-mixed antibiotic-impregnated calcium sulfate pellets? | |
Where High-Risk Adults Receive Influenza Vaccine During a Shortage | |
Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. | |
Zakażenia kości i stawów w przebiegu stopy cukrzycowej |